Expanding Partnerships Magnus has rapidly expanded its health system partnerships to 14 states through collaborations with major providers such as Cleveland Clinic, UPMC, HCA Healthcare, UTHealth Houston, Houston Methodist, Dartmouth-Hitchcock, Sutter Health, and OhioHealth, creating a broad coverage network for SAINT.

Strategic Product Lead SAINT Neuromodulation System has FDA Breakthrough Device Designation and 510(k) clearance for treatment of MDD, signaling a high-potential platform with regulatory momentum that can accelerate adoption in major health systems seeking innovative mental health solutions.

Growth Revenue With reported revenue in the range of ten to twenty-five million and a focused VP of product in neuropsychiatric treatment, there is ample opportunity to upsell additional brain stimulation programs and expand installed base within existing partner networks.

Tech & Security Magnus operates on scalable cloud and web technologies (AWS, CloudFront, MySQL, Vue.js, PHP) with security practices (HSTS) that can appeal to large health systems requiring reliable, compliant IT integration for device data management and remote monitoring.

Market Momentum The company’s nationwide expansion plan in 2026, ongoing health system launches, and strong clinical traction positions Magnus to pursue enterprise agreements, system-wide deployments, and long-term service contracts with major academic medical centers and health networks.